Phase 1 Trials Of Bharat Biotech's Nasal Vaccine For Covid-19 Now Underway: MD Dr Krishna Ella

Bharat Biotech Managing Director (MD) Dr Krishna Ella has said that the biotechnological company’s nasal vaccine for Covid-19 is currently under its phase 1 trial.

8 May is the deadline fixed for the same and Dr Ella believes that the company could very well become the first in the world to launch a Covid-19 nasal vaccine.

Dr Ella said that taking a single dose of the nasal vaccine will help break the chain of transmission and further the process of flattening the curve of Covid-19 infections.